Email address
[email protected]Contact number
+1 617 542 6000About
Provided by Mintz
Since the birth of the life sciences industry in the 1970s, Mintz Levin has provided our clients with the experience, resources, and insights to help them meet their goals. Today, we advise life science companies of every size, from start-ups looking for their first funding to public companies with products on the market, as well as venture capital firms, investment banks, research and academic institutions, and others engaged in the life sciences ecosystem.
Corporate
- IPOs, follow-on offerings, and PIPE transactions
- Reverse mergers, Form 10s, and APOs
- Securities regulatory compliance and corporate governance advice
- Mergers and acquisitions
- Strategic collaborations and licensing
- Angel and venture capital financing
- Equity compensation
Intellectual Property
- Patent prosecution and strategy
- Patent infringement litigation
- Hatch-Waxman Paragraph IV litigation
- Alternative dispute resolution
- Trademark strategy and registration
Compliance & Regulation
- FDA regulatory counseling
- Clinical trials
- Compliance planning
- Health care fraud and abuse
- Reimbursement
Clients
Provided by Mintz
Biogen Inc.
Boston Scientific Corporation
Igenica, Inc.
Intarcia Therapeutics, Inc.
NephroGenex, Inc.
Neurimmune Therapeutics AG
NeuroMetrix, Inc.
OvaScience, Inc.
QIAGEN N.V.
Regeneron
Roche Diagnostics
Rosetta Genomics Ltd.
Takeda Pharmaceuticals